ADPT Shares Outstanding History
Below is a table of the ADPT shares outstanding history going back to 6/27/2019:

Date ADPT Shares Outstanding

Also see: ADPT Market Cap History
ADPT Historical Shares Outstanding:
+7.76% CAGR
ADPT Historical Shares Outstanding: +7.76% CAGR

Mouse over chart for data details
6/27/2019 ...10/29/2021
Adaptive is comercial-stage company. Co is advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Co.'s clinical diagnostic product, clonoSEQ, is the test authorized by the Food and Drug Administration for the detection and monitoring of minimal residual disease in patients with multiple myeloma and B cell acute lymphoblastic leukemia and is being validated for patients with other blood cancers. Co.'s commercial research product, immunoSEQ, primarily serves as its underlying research and development engine to develop and validate its clinical pipeline. We show 11 historical shares outstanding datapoints in our coverage of ADPT's shares outstanding history.

Understanding the changing numbers of ADPT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADPT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADPT by allowing them to research ADPT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ADPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adaptive Biotechnologies (ADPT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ADRO Shares Outstanding History
ADTX Shares Outstanding History
ADUS Shares Outstanding History
ADVM Shares Outstanding History
ADXS Shares Outstanding History
ADYX Shares Outstanding History
AEMD Shares Outstanding History
AERI Shares Outstanding History
AEZS Shares Outstanding History
AFIB Shares Outstanding History
More Healthcare companies »


ADPT Shares Outstanding History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.